FLINDR THERAPEUTICS
Live / Registered — Registered (as of 20 May 2025)
What this means for you
Registered since 20 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98451969
- Registration number
- 7798473
- Mark type
- Stylized text
- Filed
- 15 Mar 2024
- Published for opposition
- 01 Apr 2025
- Registered
- 20 May 2025
- Attorney of record
- Erica R. Halstead
Goods and services
- Class 001 — Chemicals: Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations, namely, biologically compatible chemical substances for scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; therapeutic tissue, namely, therapeutic tissue comprising or derived from stem cells or progenitor cells, and compositions comprising or derived from the therapeutic tissues for scientific, laboratory, clinical and medical research
- Class 005 — Pharmaceuticals: Pharmaceuticals, medical and veterinary preparations for use in oncology; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology
- Class 042 — Scientific and technological services: Pharmaceutical drug discovery and development services; scientific services and research, development and design relating thereto in the field of oncology; medical research; technological services, research and design relating thereto in the fields of small molecule therapeutics; design and development of medical technology; design and development of medical diagnostic apparatus; consultancy services in the field of technological development of small molecule therapeutics; industrial analysis and industrial research services in the fields of small molecule therapeutics; design and development of computer hardware and software; design and development of small molecule therapeutics hardware; design and development of computer software for use with small molecule therapeutics hardware; clinical research in the fields of small molecule therapeutics; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, hematology and infectious disease; Medical and scientific research, namely, conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying of therapeutics for medical purposes; chemical analysis; chemical research; biotechnology research; consultancy relating to biotechnology; consultancy services relating to research and development in the field of therapeutics
Owner
- Immagene B.V., Amsterdam, NL
- Immagene B.V., Amsterdam, NL
- Immagene B.V., Amsterdam, NL
Prosecution history
- 20 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Apr 2025 — PUBLISHED FOR OPPOSITION
- 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 11 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jun 2024 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 10 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 10 Mar 2025 — ASSIGNED TO LIE
- 07 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 07 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
- 07 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
- 07 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE